Proteomics  ||| S:0 E:11 ||| NNP
and  ||| S:11 E:15 ||| CC
tubulopathies  ||| S:15 E:29 ||| NN
In  ||| S:29 E:32 ||| IN
the  ||| S:32 E:36 ||| DT
last  ||| S:36 E:41 ||| JJ
thirty  ||| S:41 E:48 ||| JJ
decade ||| S:48 E:54 ||| NN
,  ||| S:54 E:56 ||| ,
with  ||| S:56 E:61 ||| IN
the  ||| S:61 E:65 ||| DT
emergence  ||| S:65 E:75 ||| NN
of  ||| S:75 E:78 ||| IN
new  ||| S:78 E:82 ||| JJ
trends  ||| S:82 E:89 ||| NNS
in  ||| S:89 E:92 ||| IN
molecular  ||| S:92 E:102 ||| JJ
biology  ||| S:102 E:110 ||| NN
and  ||| S:110 E:114 ||| CC
advances  ||| S:114 E:123 ||| NNS
in  ||| S:123 E:126 ||| IN
high-throughput  ||| S:126 E:142 ||| JJ
technologies ||| S:142 E:154 ||| NNS
,  ||| S:154 E:156 ||| ,
much  ||| S:156 E:161 ||| JJ
progress  ||| S:161 E:170 ||| NN
has  ||| S:170 E:174 ||| VBZ
been  ||| S:174 E:179 ||| VBN
made  ||| S:179 E:184 ||| VBN
in  ||| S:184 E:187 ||| IN
basic  ||| S:187 E:193 ||| JJ
renal  ||| S:193 E:199 ||| JJ
physiology ||| S:199 E:209 ||| NN
.  ||| S:209 E:211 ||| .
Molecular  ||| S:211 E:221 ||| JJ
genetics  ||| S:221 E:230 ||| NN
has  ||| S:230 E:234 ||| VBZ
allowed  ||| S:234 E:242 ||| VBN
the  ||| S:242 E:246 ||| DT
identification  ||| S:246 E:261 ||| NN
and  ||| S:261 E:265 ||| CC
elucidation  ||| S:265 E:277 ||| NN
of  ||| S:277 E:280 ||| IN
the  ||| S:280 E:284 ||| DT
structure ||| S:284 E:293 ||| NN
,  ||| S:293 E:295 ||| ,
function  ||| S:295 E:304 ||| NN
and  ||| S:304 E:308 ||| CC
effects  ||| S:308 E:316 ||| NNS
of  ||| S:316 E:319 ||| IN
the  ||| S:319 E:323 ||| DT
mutations  ||| S:323 E:333 ||| NN
of  ||| S:333 E:336 ||| IN
several  ||| S:336 E:344 ||| JJ
of  ||| S:344 E:347 ||| IN
the  ||| S:347 E:351 ||| DT
main  ||| S:351 E:356 ||| JJ
transporters  ||| S:356 E:369 ||| NN
and  ||| S:369 E:373 ||| CC
ion  ||| S:373 E:377 ||| JJ
channels  ||| S:377 E:386 ||| NNS
involved  ||| S:386 E:395 ||| VBN
in  ||| S:395 E:398 ||| IN
renal  ||| S:398 E:404 ||| JJ
disorders ||| S:404 E:413 ||| NNS
.  ||| S:413 E:415 ||| .
Some  ||| S:415 E:420 ||| DT
renal  ||| S:420 E:426 ||| JJ
stone  ||| S:426 E:432 ||| NN
disorders ||| S:432 E:441 ||| NNS
,  ||| S:441 E:443 ||| ,
such  ||| S:443 E:448 ||| JJ
as  ||| S:448 E:451 ||| IN
cystinuria  ||| S:451 E:462 ||| NN
and  ||| S:462 E:466 ||| CC
Dent ||| S:466 E:470 ||| NNP
's  ||| S:470 E:473 ||| POS
disease ||| S:473 E:480 ||| NN
,  ||| S:480 E:482 ||| ,
have  ||| S:482 E:487 ||| VBP
been  ||| S:487 E:492 ||| VBN
found  ||| S:492 E:498 ||| VBN
to  ||| S:498 E:501 ||| TO
be  ||| S:501 E:504 ||| VB
due  ||| S:504 E:508 ||| JJ
to  ||| S:508 E:511 ||| TO
mutations  ||| S:511 E:521 ||| VB
in  ||| S:521 E:524 ||| IN
genes  ||| S:524 E:530 ||| NNS
SLC3A1  ||| S:530 E:537 ||| VBP
( ||| S:537 E:538 ||| -LRB-
type  ||| S:538 E:543 ||| NN
I ||| S:543 E:544 ||| PRP
)  ||| S:544 E:546 ||| -RRB-
( ||| S:546 E:547 ||| -LRB-
See  ||| S:547 E:551 ||| VB
the  ||| S:551 E:555 ||| DT
section  ||| S:555 E:563 ||| NN
Molecular  ||| S:563 E:573 ||| NNP
biology  ||| S:573 E:581 ||| NN
and  ||| S:581 E:585 ||| CC
genotype-phenotype  ||| S:585 E:604 ||| JJ
correlation  ||| S:604 E:616 ||| NN
in  ||| S:616 E:619 ||| IN
tubular  ||| S:619 E:627 ||| JJ
dysfunction ||| S:627 E:638 ||| NN
)  ||| S:638 E:640 ||| -RRB-
and  ||| S:640 E:644 ||| CC
SLC7A9  ||| S:644 E:651 ||| NNP
( ||| S:651 E:652 ||| -LRB-
type  ||| S:652 E:657 ||| NN
II  ||| S:657 E:660 ||| NNP
and  ||| S:660 E:664 ||| CC
type  ||| S:664 E:669 ||| NN
III ||| S:669 E:672 ||| NNP
) ||| S:672 E:673 ||| -RRB-
,  ||| S:673 E:675 ||| ,
( ||| S:675 E:676 ||| -LRB-
See  ||| S:676 E:680 ||| VB
the  ||| S:680 E:684 ||| DT
section  ||| S:684 E:692 ||| NN
Molecular  ||| S:692 E:702 ||| NNP
biology  ||| S:702 E:710 ||| NN
and  ||| S:710 E:714 ||| CC
genotype-phenotype  ||| S:714 E:733 ||| JJ
correlation  ||| S:733 E:745 ||| NN
in  ||| S:745 E:748 ||| IN
tubular  ||| S:748 E:756 ||| JJ
dysfunction ||| S:756 E:767 ||| NN
)  ||| S:767 E:769 ||| -RRB-
and  ||| S:769 E:773 ||| CC
in  ||| S:773 E:776 ||| IN
CLC5 ||| S:776 E:780 ||| NNP
,  ||| S:780 E:782 ||| ,
respectively ||| S:782 E:794 ||| RB
.  ||| S:794 E:796 ||| .
Liddle  ||| S:796 E:803 ||| JJ
syndrome ||| S:803 E:811 ||| NN
,  ||| S:811 E:813 ||| ,
a  ||| S:813 E:815 ||| DT
rare  ||| S:815 E:820 ||| JJ
cause  ||| S:820 E:826 ||| NN
of  ||| S:826 E:829 ||| IN
hypertension ||| S:829 E:841 ||| NN
,  ||| S:841 E:843 ||| ,
is  ||| S:843 E:846 ||| VBZ
now  ||| S:846 E:850 ||| RB
known  ||| S:850 E:856 ||| VBN
to  ||| S:856 E:859 ||| TO
be  ||| S:859 E:862 ||| VB
caused  ||| S:862 E:869 ||| VBN
by  ||| S:869 E:872 ||| IN
a  ||| S:872 E:874 ||| DT
mutation  ||| S:874 E:883 ||| NN
in  ||| S:883 E:886 ||| IN
tubular  ||| S:886 E:894 ||| JJ
transport ||| S:894 E:903 ||| NN
,  ||| S:903 E:905 ||| ,
due  ||| S:905 E:909 ||| JJ
to  ||| S:909 E:912 ||| TO
a  ||| S:912 E:914 ||| DT
mutation  ||| S:914 E:923 ||| NN
in  ||| S:923 E:926 ||| IN
the  ||| S:926 E:930 ||| DT
SCNN1B  ||| S:930 E:937 ||| JJ
gene ||| S:937 E:941 ||| NN
,  ||| S:941 E:943 ||| ,
encoding  ||| S:943 E:952 ||| VBG
for  ||| S:952 E:956 ||| IN
a  ||| S:956 E:958 ||| DT
Na+  ||| S:958 E:962 ||| JJ
channel  ||| S:962 E:970 ||| NN
protein  ||| S:970 E:978 ||| NN
( ||| S:978 E:979 ||| -LRB-
ENaC ||| S:979 E:983 ||| NNP
) ||| S:983 E:984 ||| -RRB-
.  ||| S:984 E:986 ||| .
Nevertheless ||| S:986 E:998 ||| RB
,  ||| S:998 E:1000 ||| ,
numerous  ||| S:1000 E:1009 ||| JJ
issues  ||| S:1009 E:1016 ||| NNS
remain  ||| S:1016 E:1023 ||| VBP
unsettled  ||| S:1023 E:1033 ||| VBN
and  ||| S:1033 E:1037 ||| CC
warrant  ||| S:1037 E:1045 ||| VB
additional  ||| S:1045 E:1056 ||| JJ
research ||| S:1056 E:1064 ||| NN
.  ||| S:1064 E:1066 ||| .
These  ||| S:1066 E:1072 ||| DT
important  ||| S:1072 E:1082 ||| JJ
advances  ||| S:1082 E:1091 ||| NNS
and  ||| S:1091 E:1095 ||| CC
discoveries  ||| S:1095 E:1107 ||| NNS
are  ||| S:1107 E:1111 ||| VBP
not  ||| S:1111 E:1115 ||| RB
without  ||| S:1115 E:1123 ||| IN
limitations  ||| S:1123 E:1135 ||| NNS
and  ||| S:1135 E:1139 ||| CC
challenges  ||| S:1139 E:1150 ||| NNS
as  ||| S:1150 E:1153 ||| IN
changes  ||| S:1153 E:1161 ||| NNS
in  ||| S:1161 E:1164 ||| IN
individual  ||| S:1164 E:1175 ||| JJ
gene  ||| S:1175 E:1180 ||| NN
expression  ||| S:1180 E:1191 ||| NNS
do  ||| S:1191 E:1194 ||| VBP
not  ||| S:1194 E:1198 ||| RB
always  ||| S:1198 E:1205 ||| RB
translate  ||| S:1205 E:1215 ||| VB
into  ||| S:1215 E:1220 ||| IN
changes  ||| S:1220 E:1228 ||| NNS
in  ||| S:1228 E:1231 ||| IN
its  ||| S:1231 E:1235 ||| PRP$
protein  ||| S:1235 E:1243 ||| NN
or  ||| S:1243 E:1246 ||| CC
protein  ||| S:1246 E:1254 ||| NN
modification ||| S:1254 E:1266 ||| NN
.  ||| S:1266 E:1268 ||| .
This  ||| S:1268 E:1273 ||| DT
raises  ||| S:1273 E:1280 ||| VBZ
proteomics  ||| S:1280 E:1291 ||| VBN
as  ||| S:1291 E:1294 ||| IN
the  ||| S:1294 E:1298 ||| DT
most  ||| S:1298 E:1303 ||| RBS
logical  ||| S:1303 E:1311 ||| JJ
next  ||| S:1311 E:1316 ||| JJ
step  ||| S:1316 E:1321 ||| NN
in  ||| S:1321 E:1324 ||| IN
our  ||| S:1324 E:1328 ||| PRP$
understanding  ||| S:1328 E:1342 ||| NN
of  ||| S:1342 E:1345 ||| IN
biological  ||| S:1345 E:1356 ||| JJ
processes ||| S:1356 E:1365 ||| NNS
,  ||| S:1365 E:1367 ||| ,
as  ||| S:1367 E:1370 ||| IN
proteins  ||| S:1370 E:1379 ||| NNS
from  ||| S:1379 E:1384 ||| IN
these  ||| S:1384 E:1390 ||| DT
deregulated  ||| S:1390 E:1402 ||| JJ
genes  ||| S:1402 E:1408 ||| NNS
are  ||| S:1408 E:1412 ||| VBP
the  ||| S:1412 E:1416 ||| DT
functional  ||| S:1416 E:1427 ||| JJ
agents  ||| S:1427 E:1434 ||| NNS
in  ||| S:1434 E:1437 ||| IN
the  ||| S:1437 E:1441 ||| DT
cells ||| S:1441 E:1446 ||| NNS
.  ||| S:1446 E:1448 ||| .
Proteomics  ||| S:1448 E:1459 ||| NNP
takes  ||| S:1459 E:1465 ||| VBZ
a  ||| S:1465 E:1467 ||| DT
global  ||| S:1467 E:1474 ||| JJ
and  ||| S:1474 E:1478 ||| CC
comprehensive  ||| S:1478 E:1492 ||| JJ
view  ||| S:1492 E:1497 ||| NN
of  ||| S:1497 E:1500 ||| IN
a  ||| S:1500 E:1502 ||| DT
system ||| S:1502 E:1508 ||| NN
,  ||| S:1508 E:1510 ||| ,
involving  ||| S:1510 E:1520 ||| VBG
in  ||| S:1520 E:1523 ||| IN
many  ||| S:1523 E:1528 ||| JJ
cases  ||| S:1528 E:1534 ||| NNS
some  ||| S:1534 E:1539 ||| DT
notion  ||| S:1539 E:1546 ||| NN
of  ||| S:1546 E:1549 ||| IN
high  ||| S:1549 E:1554 ||| JJ
throughput ||| S:1554 E:1564 ||| NN
;  ||| S:1564 E:1566 ||| :
but  ||| S:1566 E:1570 ||| CC
in  ||| S:1570 E:1573 ||| IN
contrast  ||| S:1573 E:1582 ||| NN
to  ||| S:1582 E:1585 ||| TO
genomics ||| S:1585 E:1593 ||| VB
,  ||| S:1593 E:1595 ||| ,
there  ||| S:1595 E:1601 ||| EX
is  ||| S:1601 E:1604 ||| VBZ
no  ||| S:1604 E:1607 ||| DT
single  ||| S:1607 E:1614 ||| JJ
biochemical  ||| S:1614 E:1626 ||| JJ
method  ||| S:1626 E:1633 ||| NN
that  ||| S:1633 E:1638 ||| WDT
can  ||| S:1638 E:1642 ||| MD
be  ||| S:1642 E:1645 ||| VB
used  ||| S:1645 E:1650 ||| VBN
for  ||| S:1650 E:1654 ||| IN
the  ||| S:1654 E:1658 ||| DT
analysis  ||| S:1658 E:1667 ||| NN
of  ||| S:1667 E:1670 ||| IN
all  ||| S:1670 E:1674 ||| DT
proteins ||| S:1674 E:1682 ||| NNS
.  ||| S:1682 E:1684 ||| .
Genomics  ||| S:1684 E:1693 ||| NNP
and  ||| S:1693 E:1697 ||| CC
proteomics  ||| S:1697 E:1708 ||| NNS
can  ||| S:1708 E:1712 ||| MD
complement  ||| S:1712 E:1723 ||| VB
each  ||| S:1723 E:1728 ||| DT
other  ||| S:1728 E:1734 ||| JJ
in  ||| S:1734 E:1737 ||| IN
clinical  ||| S:1737 E:1746 ||| JJ
applications  ||| S:1746 E:1759 ||| NNS
by  ||| S:1759 E:1762 ||| IN
balancing  ||| S:1762 E:1772 ||| VBG
the  ||| S:1772 E:1776 ||| DT
strengths  ||| S:1776 E:1786 ||| NNS
and  ||| S:1786 E:1790 ||| CC
weaknesses  ||| S:1790 E:1801 ||| NNS
of  ||| S:1801 E:1804 ||| IN
each  ||| S:1804 E:1809 ||| DT
individual  ||| S:1809 E:1820 ||| JJ
technology ||| S:1820 E:1830 ||| NN
.  ||| S:1830 E:1832 ||| .
Several  ||| S:1832 E:1840 ||| JJ
proteomics  ||| S:1840 E:1851 ||| JJ
approaches  ||| S:1851 E:1862 ||| NNS
have  ||| S:1862 E:1867 ||| VBP
been  ||| S:1867 E:1872 ||| VBN
exploited  ||| S:1872 E:1882 ||| VBN
to  ||| S:1882 E:1885 ||| TO
shed  ||| S:1885 E:1890 ||| VB
more  ||| S:1890 E:1895 ||| JJR
light  ||| S:1895 E:1901 ||| NN
on  ||| S:1901 E:1904 ||| IN
the  ||| S:1904 E:1908 ||| DT
molecular  ||| S:1908 E:1918 ||| JJ
pathophysiology  ||| S:1918 E:1934 ||| NN
of  ||| S:1934 E:1937 ||| IN
several  ||| S:1937 E:1945 ||| JJ
hereditary  ||| S:1945 E:1956 ||| JJ
tubular  ||| S:1956 E:1964 ||| JJ
disorders ||| S:1964 E:1973 ||| NNS
,  ||| S:1973 E:1975 ||| ,
such  ||| S:1975 E:1980 ||| JJ
as  ||| S:1980 E:1983 ||| IN
Fanconi  ||| S:1983 E:1991 ||| NNP
and  ||| S:1991 E:1995 ||| CC
Gitelman  ||| S:1995 E:2004 ||| NNP
syndromes ||| S:2004 E:2013 ||| NN
,  ||| S:2013 E:2015 ||| ,
and  ||| S:2015 E:2019 ||| CC
have  ||| S:2019 E:2024 ||| VBP
provided  ||| S:2024 E:2033 ||| VBN
important  ||| S:2033 E:2043 ||| JJ
insights  ||| S:2043 E:2052 ||| NNS
into  ||| S:2052 E:2057 ||| IN
the  ||| S:2057 E:2061 ||| DT
defective  ||| S:2061 E:2071 ||| JJ
molecular  ||| S:2071 E:2081 ||| JJ
mechanisms  ||| S:2081 E:2092 ||| NNS
underlying  ||| S:2092 E:2103 ||| VBG
these  ||| S:2103 E:2109 ||| DT
tubulopathies ||| S:2109 E:2122 ||| NN
.  ||| S:2122 E:2124 ||| .
Here  ||| S:2124 E:2129 ||| RB
we  ||| S:2129 E:2132 ||| PRP
summarize  ||| S:2132 E:2142 ||| VBP
several  ||| S:2142 E:2150 ||| JJ
of  ||| S:2150 E:2153 ||| IN
the  ||| S:2153 E:2157 ||| DT
most  ||| S:2157 E:2162 ||| RBS
important  ||| S:2162 E:2172 ||| JJ
discoveries  ||| S:2172 E:2184 ||| NNS
arising  ||| S:2184 E:2192 ||| VBG
from  ||| S:2192 E:2197 ||| IN
molecular  ||| S:2197 E:2207 ||| JJ
genetic  ||| S:2207 E:2215 ||| JJ
and  ||| S:2215 E:2219 ||| CC
proteomic  ||| S:2219 E:2229 ||| JJ
studies  ||| S:2229 E:2237 ||| NNS
on  ||| S:2237 E:2240 ||| IN
hereditary  ||| S:2240 E:2251 ||| JJ
tubular  ||| S:2251 E:2259 ||| JJ
dysfunctions  ||| S:2259 E:2272 ||| NN
and  ||| S:2272 E:2276 ||| CC
show  ||| S:2276 E:2281 ||| VB
how  ||| S:2281 E:2285 ||| WRB
these  ||| S:2285 E:2291 ||| DT
results  ||| S:2291 E:2299 ||| NNS
can  ||| S:2299 E:2303 ||| MD
complement  ||| S:2303 E:2314 ||| VB
each  ||| S:2314 E:2319 ||| DT
other  ||| S:2319 E:2325 ||| JJ
to  ||| S:2325 E:2328 ||| TO
increase  ||| S:2328 E:2337 ||| VB
our  ||| S:2337 E:2341 ||| PRP$
comprehension  ||| S:2341 E:2355 ||| NN
of  ||| S:2355 E:2358 ||| IN
these  ||| S:2358 E:2364 ||| DT
disorders  ||| S:2364 E:2374 ||| NNS
at  ||| S:2374 E:2377 ||| IN
the  ||| S:2377 E:2381 ||| DT
molecular  ||| S:2381 E:2391 ||| JJ
level ||| S:2391 E:2396 ||| NN
.  ||| S:2396 E:2398 ||| .
